Welcome to our dedicated page for Bon Natural Life news (Ticker: BON), a resource for investors and traders seeking the latest updates and insights on Bon Natural Life stock.
Bon Natural Life Limited develops, manufactures, and commercializes bio-ingredient solutions for natural health, functional food, personal care, cosmetic, and related applications. Its product base includes plant-derived extracts, fragrance compounds, health supplements, bioactive food ingredients, functional food ingredients, and personal care actives, with recurring updates tied to apple polyphenols, tea pigments, and natural active ingredients.
Company news commonly covers product development, distribution and sales cooperation agreements, research collaborations, and manufacturing technology. Recent themes include Apple Series health products, tea pigment digestive health products, kombucha-inspired functional beverages, AI-enabled bio-manufacturing initiatives, flexible bio-electronic skin-care applications, and Nasdaq listing-compliance matters.
Bon Natural Life Limited (Nasdaq: BON) will release its half-year earnings report for the period ending March 31, 2021, before the market opens on August 17, 2021. The company will host an investor conference call at 8:30 a.m. EST on the same day, featuring key executives including CEO Richard Yongwei Hu. Participants can pre-register for easier access or join via dial-in options. Bon Natural focuses on the production of bio-ingredient solutions for health and personal care industries. For more information, visit www.bnlus.com.
Bon Natural Life Limited (Nasdaq: BON) has commenced construction of its third production facility in Yumen City, aiming to boost production capacity of fragrance compounds and bioactive food ingredients by 200%. This expansion is anticipated to yield a 150% annual growth in revenue upon completion, scheduled between June and September 2022. The facility will feature 6 state-of-the-art production lines and is expected to enhance operational efficiency while meeting increasing demand. The project is seen as a significant step toward expanding BON's global presence, particularly in international markets like the U.S. and Europe.
Bon Natural Life Limited (Nasdaq: BON) announced the acquisition of land for its third production facility in Yumen, China, which will boost overall production capacity by over 200%. The facility will cover 8.2 acres and is expected to enhance access to raw materials and export capability to European markets. Construction is set to begin in July 2021, with completion anticipated in June 2022. Post-construction, production is expected to increase from 170 tons to 520 tons by September 2022, significantly supporting domestic and international demand.
Bon Natural Life Limited (Nasdaq: BON) announced the issuance of an additional 330,000 ordinary shares at $5.00 per share, raising $1.65 million, following the full exercise of the underwriters' over-allotment option during its initial public offering (IPO). This brings the total shares sold in the IPO to 2,530,000, with gross proceeds of $12.65 million. The shares began trading on June 24, 2021. U.S. Tiger Securities and Newbridge Securities acted as co-lead managers for the offering. The registration statements related to the offering were declared effective on June 23, 2021.
Bon Natural Life Limited (Nasdaq: BON) completed its initial public offering, selling 2,200,000 shares at $5.00 each, raising gross proceeds of $11.0 million. The firm also granted underwriters a 45-day option for an additional 330,000 shares. The proceeds will be utilized to enhance production, expand sales and distribution networks, invest in R&D, and for working capital. Shares began trading on the Nasdaq on June 24, 2021.
Bon Natural Life Limited (Nasdaq: BON) has priced its initial public offering (IPO) of 2,200,000 ordinary shares at $5.00 per share, raising approximately $11.0 million in gross proceeds. The offering includes an option for underwriters to purchase an additional 330,000 shares. Trading is set to begin on June 24, 2021, with the offering expected to close around June 28, 2021, subject to customary conditions. Proceeds will be used for working capital, expanding the sales network, research, and production capacity.